Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years

NCT: NCT03455582 · COMPLETED

NCT IDNCT03455582
StatusCOMPLETED
Start Date2018-09-24
Completion2026-04-15
SponsorUniversity Hospital, Bordeaux (OTHER)
First posted
Last updated

Brief Summary

Cognitive impairment is nowadays more and more recognized as an important feature of the multiple sclerosis (MS) disease. Cognitive disorders frequency in MS is estimated between 40 and 60%. Cognitive impairment affects quality of life and vocational status in MS patients. Until recently, little information was available on the cognitive dysfunction and their evolution that occur in primary progressive multiple sclerosis (PPMS) as compared with relapsing-remitting MS (RRMS). In PPMS pathological studies have shown the importance of cortical demyelination and meningeal inflammation suggesting that the GM alteration could play a major role in the cognitive impairment in this phenotype. The cognitive evolution and the brain tissue alteration at the origin of these difficulties remain poorly understood in PPMS. The use of new techniques for morphological and functional MRI can study the contribution of diffuse White Matter (WM) alteration (probably through disconnexion of relevant network) and diffuse Grey matter (GM) alterations in the cerebral cortex and other structures (the hippocampi, the cerebellum, and the thalami) in cognitive impairment in PPMS patients and on their evolution.

Frequently Asked Questions

What is Cognition Evolution and MRI Markers in PPMS Patients on 2 Years?

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years is a clinical trial registered under NCT03455582. Current status: COMPLETED.

What is the status of NCT03455582?

The current status of NCT03455582 (Cognition Evolution and MRI Markers in PPMS Patients on 2 Years) is: COMPLETED.

When did Cognition Evolution and MRI Markers in PPMS Patients on 2 Years start?

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years started on 2018-09-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.